Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
91 participants
INTERVENTIONAL
2013-08-31
2019-05-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transfer of Grasp Control Across Hands After Stroke
NCT00589368
Optimizing Transcranial Direct Current Stimulation for Motor Recovery From Severe Post-stroke Hemiparesis
NCT04574973
Ischemic Nerve Block to Improve Hand Function in Stroke Patients
NCT00056706
Study of the Recovery of Muscle Function in the Arm/Hand After a Stroke
NCT01422005
Mechanisms of Arm Recovery in Stroke Patients With Hand Paralysis
NCT03067818
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Hypotheses: We hypothesize that alternate hand training will increase the rate of learning and lead to greater improvement in hand function. The results will inform dosing of therapy for optimal relearning.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stroke & age-matched Controls
Alternate Hand Training or Affected Hand Training:
40 patients with stroke and 40 control subjects will participate over 7 visits. After completion of informed consent, subjects will undergo clinical assessments (Visit 1) which will involve testing for kinesthetic, visual, tactile and motor impairments and upper limb function. Visit 2, subjects will undergo no contrast MRI to identify lesion location. Healthy controls will not be imaged.
Visits 3-7 will involve psychophysical experiments to test adaptation with short-term Alternate Hand Training and Affected Hand Training. During 5 visits the subjects will grasp and lift an instrumented grip device of different weights, textures and shapes while data is being collected via surface electrodes from, upper arm and back muscles.
Alternate Hand Training or Affected Hand Training
Participants will receive a training intervention with either the Alternate Hand Training Strategy, or Affected Hand Training alone.
Phase 2 - Stroke ONLY
Alternate Hand Training or Affected Hand Training:
Subjects will be randomized into two groups one receiving Alternate Hand Training and the other receiving Affected Hand Training. The groups will be matched by age, gender, handedness, side of lesion, extent of motor impairment and lesion location. They will complete 17 Study visits.
Visits 1 and 2 will involve clinical assessments and MRI. Visit 3. Pre-intervention assessments involving grasping and lifting objects of different weights, textures and shapes while fingertip forces, finger and arm movements. Muscle activity and performance is measured.
Visits 4-15. Subjects will participate in 12 training visits for 1 hour a day, twice a week for 6 weeks.
Visits 16-17. Recovery of hand function will be measured by repeating the pre-intervention clinical and grasping assessments (in 2 visits) immediately after 6-weeks of training, and another 6 weeks later.
Alternate Hand Training or Affected Hand Training
Participants will receive a training intervention with either the Alternate Hand Training Strategy, or Affected Hand Training alone.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Alternate Hand Training or Affected Hand Training
Participants will receive a training intervention with either the Alternate Hand Training Strategy, or Affected Hand Training alone.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \> 18 yrs
* Radiologically verified stroke \> 4 months old (3T structural MRI)
* Moderate arm motor impairment (Fugl-Meyer Scale \< 60/66)
* Ability to reach, grasp and lift the test objects with the affected side as assessed by the PI
* Willingness to complete all clinical assessments and MRI, and comply with training protocols
Exclusion Criteria
* Severe visual or sensory impairment, including neglect on the affected side
* Significant cognitive dysfunction (score \< 24 on Folstein's Mini Mental Status Examination)
* Severe or unstable spasticity on treatment with Botulinum toxin or intrathecal baclofen
* Depression (Geriatric Depression Scale score \<11)
* Major disability (modified Rankin Scale \> 4)
* Previous neurological illness, complicated medical condition, or significant injury to either upper extremity
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
NYU Langone Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John R Rizzo, MD
Role: PRINCIPAL_INVESTIGATOR
NYU Langone Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New York University School of Medicine
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1R01HD071978-01A1102617
Identifier Type: OTHER
Identifier Source: secondary_id
12-03117
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.